Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
mRNA | MBD1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
mRNA | ZNF559-ZNF177 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
mRNA | ZNF517 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | ZNF43 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |